Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Molecular subtype classification of urothelial carcinoma in Lynch syndrome

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Harnessing data science to advance radiation oncology

    Research output: Contribution to journalReviewpeer-review

  2. Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Using microarray-based subtyping methods for breast cancer in the era of high-throughput RNA sequencing

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. An Update on Immune Checkpoint Therapy for the Treatment of Lynch Syndrome

    Research output: Contribution to journalReviewpeer-review

  2. The influence of marital status and partner concordance on participation in colorectal cancer screening

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Lynch syndrome confers an increased risk for urothelial carcinoma (UC). Molecular subtypes may be relevant to prognosis and therapeutic possibilities, but have to date not been defined in Lynch syndrome-associated urothelial cancer. We aimed to provide a molecular description of Lynch syndrome-associated UC. Thus, Lynch syndrome-associated UC of the upper urinary tract and the urinary bladder were identified in the Danish hereditary non-polyposis colorectal cancer (HNPCC) register and were transcriptionally and immunohistochemically profiled and further related to data from 307 sporadic urothelial carcinomas. Whole genome mRNA expression profiles of 41 tumors and immunohistochemical stainings against FGFR3, KRT5, CCNB1, RB1, and CDKN2A (p16) of 37 tumors from Lynch syndrome patients were generated. Pathological data, microsatellite instability, anatomic location, and overall survival data was analyzed and compared with sporadic bladder cancer. The 41 Lynch syndrome-associated UC developed at a mean age of 61 years with 59% women. mRNA expression profiling and immunostaining classified the majority of the Lynch syndrome-associated UC as Urothelial-like tumors with only 20% being Genomically Unstable, Basal/SCC-like or other subtypes. The subtypes were associated with stage, grade, and microsatellite instability. Comparison to larger data sets revealed that Lynch syndrome-associated UC share molecular similarities with sporadic UC. In conclusion, transcriptomic and immunohistochemical profiling identifies a predominance of the Urothelial-like molecular subtype in Lynch syndrome and reveals that the molecular subtypes of sporadic bladder cancer are relevant also within this hereditary, mismatch-repair defective subset. This article is protected by copyright. All rights reserved.

Original languageEnglish
JournalMolecular Oncology
Volume12
Issue number8
Pages (from-to)1286-1295
ISSN1574-7891
DOIs
Publication statusPublished - 1 Aug 2018

ID: 54585574